WHAT IS STEM CELL TECHNOLOGY
Vet-Stem Regenerative Cell Therapy is based on a clinical technology originally licensed from Artecel Inc., Sunnyvale, CA. Original patents from University of Pittsburgh and Duke University.
- Rationale based on consistent therapeutic success in numerous animal models of disease (see sidebar)
- Adipose-derived adult stem cells (Vet-Stem Regenerative Cells: VSRC™)
- Autologous cell therapy
- Currently used in horses with bowed tendons, ligament injuries, and fractures, and in dogs with osteoarthritis
- More than 2,000 horses treated since 2003
- No systemic adverse events reported and <>3-6
- Demonstrated efficacy with VSRC therapy in horses and dogs
- Cornell University double-blind, placebo controlled study5
- Retrospective studies3,4
- Case studies6
Adipose-derived regenerative cells are:
- Readily available source
- Can be collected in far greater concentrations than those from bone marrow24
- Able to differentiate into multiple lineages implicating their potential in bone, cartilage, and cardiac repair23 (See figure above)
- Fractions isolated from adipose tissue contain a heterogeneous mixture of regenerative cells, including:23
- Mesenchymal stem cells
- Endothelial progenitor cells
- Pericytes
- Immune cells
- Fibroblasts
- Other growth factor-secreting bioactive cells
- Does not rely on a single target receptor or a single pathway for its action
- Regenerative cell mixture is delivered either directly to the traumatic wound (e.g.: tendonitis, desmitis, fracture) or are delivered systemically (e.g.: liver disease, renal disease)
- Regenerative cells can differentiate into many tissue types, induce repair, and stimulate regeneration22
- Regenerative cells "communicate" with the cells of their local environment through paracrine and autocrine modalities, creating the optimal environment for natural healing25
- Regenerative cells produce a variety of both secreted and cell surface substances that regulate tissue growth, integrity, and function25
No comments:
Post a Comment